Close

Analyst Ratings for Monopar Therapeutics (MNPR)

MNPR Rating Summary

MNPR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MNPR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $2.00 (+203%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/11/2024 Jones Trading Soumit Roy Upgrade Buy
(Hold)
2.00
(N/A)
0.64
(0.66)
3.13% Details
3/29/2023 Maxim Group Jason McCarthy Downgrade Hold
(Buy)
N/A
(N/A)
1.45
(0.66)
-54.48% Details